Investment Summary

OPK Biotech Exits Biopure

On April 21, 2010, invested in life science company Biopure from OPK Biotech

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is transaction in the United States.
  • This is transaction in Massachusetts.

Investment Summary

Date 2010-04-21
Target Biopure
Sector Life Science
Sellers(s) OPK Biotech
Deal Type Bankruptcy

Target

Biopure

Cambridge, Massachusetts, United States
Biopure Corp. is a biopharmaceutical company that specializes in oxygen therapeutics for both human and veterinary use.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Seller(S) 1

SELLER

OPK Biotech

Delaware, United States

Category Company
Sector Life Science
DESCRIPTION

OPK Biotech, LLC was incorporated in 2009 and is based in Delaware.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Bankruptcy M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2010 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-25 Biopure

Cambridge, Massachusetts, United States

Biopure Corp. is a biopharmaceutical company that specializes in oxygen therapeutics for both human and veterinary use.

Buy -